Citron Rho Interacting Kinase (CRIK) Regulates Survival in IL-6 Dependent Multiple Myeloma Cells.

被引：0
|
作者：
Ngo, Hai T. [1 ]
Leontovich, Alexey A. [2 ]
Roccaro, Aldo M. [1 ]
Azab, Abdel Kareem [1 ]
Runnels, Judith M. [1 ]
Azab, Feda [1 ]
Sacco, Antonio [1 ]
Quang, Phong [1 ]
Anderson, Kenneth C. [1 ]
Ghobrial, Irene M. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Mayo Clin, Coll Med, Rochester, MN USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：725 / 725
页数：1
相关论文
共 50 条
  • [1] Proteomic Studies Identify Citron Rho Interacting Kinase (CRIK), a Novel Protein That Regulates Proliferation and Survival In Multiple Myeloma Cells
    Ngo, Hai T.
    Roccaro, Aldo M.
    Leontovich, Alexey
    Liu, Yang
    Zhang, Yong
    Azab, Abdel Kareem A.
    Sacco, Antonio
    Still, Eric
    Morgan, Brittany
    Anderson, Kenneth C.
    Ghobrial, Irene
    BLOOD, 2010, 116 (21) : 1220 - 1220
  • [2] IL-6 induction of telomerase in multiple myeloma cells.
    Nho, RS
    Van Ness, B
    BLOOD, 2000, 96 (11) : 752A - 752A
  • [3] Citron Rho-Interacting Serine/Threonine kinase (CIT) Is a Novel Therapeutic Target in Multiple Myeloma Cells
    Kawano, Yawara
    Sahin, Ilyas
    Moschetta, Michele
    Wang, Jinhua
    Manier, Salomon
    Glavey, Siobhan
    Mishima, Yuji
    Kokubun, Katsutoshi
    Tsukamoto, Shokichi
    Sacco, Antonio
    Anderson, Kenneth C.
    Roccaro, Aldo M.
    Gray, Nathanael S.
    Ghobrial, Irene M.
    BLOOD, 2014, 124 (21)
  • [4] Inhibition of tyrosine kinase causes apoptosis and down-regulation of NFκB in IL-6 dependent and independent multiple myeloma cells.
    Huang, Q
    Ergin, M
    Ni, HY
    Qin, JZ
    Amin, HM
    Alkan, S
    BLOOD, 2000, 96 (11) : 750A - 750A
  • [5] Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma
    Sahin, Ilyas
    Kawano, Yawara
    Sklavenitis-Pistofidis, Romanos
    Moschetta, Michele
    Mishima, Yuji
    Manier, Salomon
    Sacco, Antonio
    Carrasco, Ruben
    Fonseca, Rafael
    Roccaro, Aldo M.
    Witzig, Thomas
    Ghobrial, Irene M.
    BLOOD ADVANCES, 2019, 3 (07) : 995 - 1002
  • [6] In vitro activity of IL-6 receptor super-antagonists on multiple myeloma cells.
    Petrucci, MT
    Ricciardi, MR
    Savino, R
    Sporeno, E
    Ciliberto, G
    Mandelli, F
    Tafuri, A
    BLOOD, 1995, 86 (10) : 232 - 232
  • [7] Azacitidine down-regulates both IL-6 signalling and NFkB activity in human myeloma cells.
    Khong, Tiffany
    Spencer, Andrew
    BLOOD, 2006, 108 (11) : 982A - 982A
  • [8] Consequence of IL-6 receptor α overexpression on IL-6-induced signals in myeloma cells.
    Abroun, S
    Ishikawa, H
    Tsuyama, N
    Liu, SQ
    Li, FJ
    Otsuyama, K
    Xu, Z
    Kawano, MM
    BLOOD, 2002, 100 (11) : 607A - 607A
  • [9] Transcriptional regulation of autocrine IL-6 expression in multiple myeloma cells
    Gerlo, Sarah
    Haegeman, Guy
    Vanden Berghe, Wim
    CELLULAR SIGNALLING, 2008, 20 (08) : 1489 - 1496
  • [10] URI regulates tumorigenicity and chemotherapeutic resistance of multiple myeloma by modulating IL-6 transcription
    J-L Fan
    J Zhang
    L-W Dong
    W-J Fu
    J Du
    H-G Shi
    H Jiang
    F Ye
    H Xi
    C-Y Zhang
    J Hou
    H-Y Wang
    Cell Death & Disease, 2014, 5 : e1126 - e1126
12345